DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Pentastarch is an investigational drug.
There have been 5 clinical trials for Pentastarch. The most recent clinical trial was a Phase 2 trial, which was initiated on February 1st 2009.
The most common disease conditions in clinical trials are Shock, Shock, Traumatic, and Shock, Hemorrhagic. The leading clinical trial sponsors are Sangart, Children's & Women's Health Centre of British Columbia, and Hamilton Health Sciences Corporation.
Recent Clinical Trials for Pentastarch
|Phase IIb Study of MP4OX in Traumatic Hemorrhagic Shock Patients||Sangart||Phase 2|
|Phase IIa Study of MP4OX in Traumatic Hemorrhagic Shock Patients||Sangart||Phase 2|
|Fluid Resuscitation in Early Septic Shock||Baxter Healthcare Corporation||Phase 2|